Tag | Content |
---|
EnhancerAtlas ID | HS023-16277 |
Organism | Homo sapiens |
Tissue/cell | CD8+ |
Coordinate | chr20:48416430-48418190 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
FOSL2 | MA0478.1 | chr20:48417366-48417377 | ATGAGTCATCC | - | 6.62 | JUN(var.2) | MA0489.1 | chr20:48416562-48416576 | GTGAGTCATTCCCT | - | 6.31 | JUN(var.2) | MA0489.1 | chr20:48417366-48417380 | ATGAGTCATCCTTT | - | 7.08 | JUNB | MA0490.1 | chr20:48417366-48417377 | ATGAGTCATCC | - | 6.62 | ZNF263 | MA0528.1 | chr20:48416591-48416612 | AGAGGAGAGGGTGAAGAAGGA | + | 6.18 | Zfx | MA0146.2 | chr20:48417968-48417982 | GAGGCCGAGGCGGG | - | 6.01 |
|
| Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
SE_10052 | chr20:48416546-48417962 | CD14 | SE_53571 | chr20:48416214-48416892 | Spleen | SE_53571 | chr20:48417110-48418014 | Spleen | SE_59121 | chr20:48392206-48441118 | Ly3 | SE_60900 | chr20:48401596-48463292 | DHL6 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 3 | Chromosome | Start | End |
chr20 | 48417278 | 48417603 | chr20 | 48417195 | 48417606 | chr20 | 48416880 | 48416976 |
|
| Number: 2 | ID | Chromosome | Start | End |
GH20I049801 | chr20 | 48416880 | 48416976 | GH20I049800 | chr20 | 48417138 | 48417937 |
|
Enhancer Sequence | ATCTGCTTTG ACCTTTGAGA CGAATGCATG GAGATCTATT GATCGGATGG GCCACGTTTG 60 TTTCCCACAC TTCGTTGAAA AATTGGGGGT GAAAAAAACT GGGAGTGAAA AAATGGCCAA 120 ACCAAAAGAA GGGTGAGTCA TTCCCTCCTA CCCCAAAATA CAGAGGAGAG GGTGAAGAAG 180 GAGGACCGCC CCTCCTCGCT CCAGTAAAGC CTTTAACAGG CCCATCCTGA TTTACAGGGA 240 GCGGACTTGG TTTCCTGTTC AAGAATTTCC AAGGCAAAAA CAATCCTCAA ACACATGAAG 300 ATGAGGTTGG GCAAATAACT CATGGATGGT CTCAACGCTG GAGGGCAAAG TTGTTTATTA 360 AGCTCCCGAC CCTCAAAGGG AATTACTTAA ATTTTTTTCT TGATTATAAA AGTAGTATTC 420 CAGCCTGGGC AACAAGAGCG AGACTCCATC TCAAAAAAAA AAAAAAAAAA AAAAAGTATT 480 GGCTCATCAC TATGAAAAAG CATTTTCAGA GAATACAGAA AAGTGTGAGG AATAGAATAA 540 AAAACAGTCA TAATTTTGGA GCATTTTGTA AGTTAGCCCA TAGATTTTTT AAATGCATAC 600 ACATGTACTT AATTCTAAAG TGAACCTGTG CTATCTTTTT ATTTAACAGT AATCCTAAGA 660 TTTATTGAGT ATGTACAATG CATATGCTAG TTGCTCTCTG TGTATTAATC CATTTTATAT 720 TTACAGTAGT CCTGTGTGAT AAGCACTATT ATTAATTCAA TTTTATAGAT GGGGAAACTG 780 AGGCAGAGAG CAGTTAAGTG ATTTACCCAA GATCACACAA GGTGGCCAAG CTGGAATTCA 840 GAAACAAGTA ATCTGGCTTC AAGGCCCATG ACGTTAACCA CTATACTACA TTGCTAAGGC 900 AGAGCAGAGA CCCCTCCCAA GTTAATACCC ATAGATATGA GTCATCCTTT TTAGTGCCTG 960 CACTTATTCT TCTATTACTA GATAATTGGG CTTTTTCTAG TTTCCCCCTA CTAGGAAATA 1020 GAGAGAAACT TCCCTTTTGG GCTTTAAATT AGACAAGAAA ATATGCGGTT AGATGTCACC 1080 ACAACTTGTA CTTCTTTTTT TTTTTTTTTT TTTTGAGACA GGGCTCGCTC TGTCACCCAG 1140 GCTGGAGTGC AGTGGTGCGA TCACAGCTCA CTGCAGCTTT GACCTCCCAG GCTCAATCTA 1200 TTCTCCCGCC TCAATCTATT CTCCCACTTC AGCCTTCTGA GTAGTTGGGA CTACAAGTGC 1260 ACACCACCGT GCCTGACTAT TTATTTCTCT TTTCTGTAGA CATGGGGTCT CACTGTGTTG 1320 CCCAGGCTAA CAACTGGTAT TTCTAACCCA GGAGAAGCAA CGAAGGGCTC AGCCCTACTT 1380 TGAAGCAATC GCCCCATTAT GCACATATAT ATTGACTGGG GGAGGTTATT TTATTTAAGA 1440 AACATCCATG AAGTACTTAT GTGCCAGACA GACATGGCTT CAAGAACTTC TGAATAGGCT 1500 GGGCACGGTG GCTCACGCCT GTAATCCCAA CACTTTGGGA GGCCGAGGCG GGCGGATCAC 1560 GAGGTCAGGA ATTCGAGACC AGCCTGGCCA ACATGGTGAA ACCCCGTCTC TACTAAAAAT 1620 ACAAAAACTT AGCTGGGCGT GGTGGTGGGC GCCTGTAATT CCAGCTACTT GGGAGGCTGA 1680 GGCAGGAGAA TTGCTTGAAC CCAGGAGGCA GAGGTTGCAG TGCAGTGATC CGAGGTCACG 1740 CCATTGCACT CCAGCCTGGG 1760
|